Package 16714-927-01

Brand: azacitidine

Generic: azacitidine
NDC Package

Package Facts

Identity

Package NDC 16714-927-01
Digits Only 1671492701
Product NDC 16714-927
Product ID 16714-927_946ea9fe-07aa-b87b-d702-482df4bd4afe
Description

1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (16714-927-01)

Marketing

Marketing Status
Marketed Since 2019-05-08
Brand azacitidine
Generic azacitidine
Sample Package No

Linked Drug Pages (1)

Azacitidine ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "946ea9fe-07aa-b87b-d702-482df4bd4afe", "openfda": {"nui": ["N0000000233", "N0000175595"], "upc": ["0316714927015"], "unii": ["M801H13NRU"], "rxcui": ["485246"], "spl_set_id": ["81366ec1-9689-4857-ded6-3d6342fe5132"], "pharm_class_epc": ["Nucleoside Metabolic Inhibitor [EPC]"], "pharm_class_moa": ["Nucleic Acid Synthesis Inhibitors [MoA]"], "manufacturer_name": ["NorthStar RxLLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (16714-927-01)", "package_ndc": "16714-927-01", "marketing_start_date": "20190508"}], "brand_name": "Azacitidine", "product_id": "16714-927_946ea9fe-07aa-b87b-d702-482df4bd4afe", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Nucleic Acid Synthesis Inhibitors [MoA]", "Nucleoside Metabolic Inhibitor [EPC]"], "product_ndc": "16714-927", "generic_name": "Azacitidine", "labeler_name": "NorthStar RxLLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Azacitidine", "active_ingredients": [{"name": "AZACITIDINE", "strength": "100 mg/1"}], "application_number": "ANDA201537", "marketing_category": "ANDA", "marketing_start_date": "20190508", "listing_expiration_date": "20261231"}